The number of sites performing hyperpolarized [1-13C]pyruvate human studies is increasing every year. We relate metrics used in quality control (QC) of a polarized sample to traditional metrics of signal quality in vivo in 24 hyperpolarized human prostate exams. The QC metrics of injected volume and injection time are significantly correlated with the maximum [1-13C]pyruvate SNR in vivo (r=0.68, p<0.01; r=-0.48,p=0.05, respectively) and the number of voxels with estimated usable SNR (r=0.70, p<0.01; r=-0.59, p=0.01, respectively). These metrics have improved over the course of this trial with team coordination and can be improved at other sites beginning hyperpolarized human research.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords